{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:54:58Z","timestamp":1791136498867,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T00:00:00Z","timestamp":1127433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00432-005-0036-x","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T18:24:47Z","timestamp":1127413487000},"page":"1-8","source":"Crossref","is-referenced-by-count":58,"title":["Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt\u2019s lymphoma cells"],"prefix":"10.1007","volume":"132","author":[{"given":"Mei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Kutsuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Mei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian V.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,23]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/JVI.61.5.1743-1746.1987","volume":"61","author":"A Adams","year":"1987","unstructured":"Adams A (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61:1743\u20131746","journal-title":"J Virol"},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","volume":"296","author":"TR Brummelkamp","year":"2002","unstructured":"Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550\u2013553","journal-title":"Science"},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/sj.onc.1206894","volume":"22","author":"K Butz","year":"2003","unstructured":"Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F (2003) siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22:5938\u20135945","journal-title":"Oncogene"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/JVI.67.8.4875-4885.1993","volume":"67","author":"MR Chen","year":"1993","unstructured":"Chen MR, Middeldorp JM, Hayward SD (1993) Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol 67:4875\u20134885","journal-title":"J Virol"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.73.4.3154-3161.1999","volume":"73","author":"MG Davenport","year":"1999","unstructured":"Davenport MG, Pagano JS (1999) Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 73:3154\u20133161","journal-title":"J Virol"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0076-6879(92)16035-I","volume":"216","author":"S la Luna de","year":"1992","unstructured":"de la Luna S, Ortin J (1992) pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol 216:376\u2013385","journal-title":"Methods Enzymol"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrm1129","volume":"4","author":"DM Dykxhoorn","year":"2003","unstructured":"Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457\u2013467","journal-title":"Nat Rev Mol Cell Biol"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494\u2013498","journal-title":"Nature"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JVI.69.4.2633-2636.1995","volume":"69","author":"TA Gahn","year":"1995","unstructured":"Gahn TA, Sugden B (1995) An EBNA-1-dependent enhancer acts from a distance of ten kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69:2633\u20132636","journal-title":"J Virol"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710\u20131715","journal-title":"J Immunol"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V84.11.3792.bloodjournal84113792","volume":"84","author":"FA Grasser","year":"1994","unstructured":"Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Mueller-Lantzsch N (1994) Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin\u2019s disease. Blood 84:3792\u20133798","journal-title":"Blood"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.73.2.965-975.1999","volume":"73","author":"G Habeshaw","year":"1999","unstructured":"Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB (1999) Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt\u2019s lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73:965\u2013975","journal-title":"J Virol"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1128\/JVI.77.10.6066-6069.2003","volume":"77","author":"AH Hall","year":"2003","unstructured":"Hall AH, Alexander KA (2003) RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77:6066\u20136069","journal-title":"J Virol"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature02870","volume":"431","author":"GJ Hannon","year":"2004","unstructured":"Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431:371\u2013378","journal-title":"Nature"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0042-6822(88)90546-6","volume":"164","author":"G Hatfull","year":"1988","unstructured":"Hatfull G, Bankier AT, Barrell BG, Farrell PJ (1988) Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334\u2013340","journal-title":"Virology"},{"key":"36_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/JVI.44.1.311-320.1982","volume":"44","author":"M Heller","year":"1982","unstructured":"Heller M, van Santen V, Kieff E (1982) Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections. J Virol 44:311\u2013320","journal-title":"J Virol"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1073\/pnas.94.15.8156","volume":"94","author":"S Huang","year":"1997","unstructured":"Huang S, Stupack D, Mathias P, Wang Y, Nemerow G (1997) Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes. Proc Natl Acad Sci USA 94:8156\u20138161","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1073\/pnas.98.4.1865","volume":"98","author":"SC Hung","year":"2001","unstructured":"Hung SC, Kang MS, Kieff E (2001) Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc Natl Acad Sci USA 98:1865\u20131870","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.onc.1206149","volume":"22","author":"A Isaksson","year":"2003","unstructured":"Isaksson A, Berggren M, Ricksten A (2003) Epstein-Barr virus U leader exon contains an internal ribosome entry site. Oncogene 22:572\u2013581","journal-title":"Oncogene"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","volume":"22","author":"BF Israel","year":"2003","unstructured":"Israel BF, Kenney SC (2003) Virally targeted therapies for EBV-associated malignancies. Oncogene 22:5122\u20135130","journal-title":"Oncogene"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1038\/sj.onc.1205878","volume":"21","author":"M Jiang","year":"2002","unstructured":"Jiang M, Milner J (2002) Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21:6041\u20136048","journal-title":"Oncogene"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V92.5.1721","volume":"92","author":"JL Kenney","year":"1998","unstructured":"Kenney JL, Guinness ME, Curiel T, Lacy J (1998) Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood 92:1721\u20131727","journal-title":"Blood"},{"key":"36_CR23","unstructured":"Kieff E (1996) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn, vol 2. Lippincott-Raven Publishers, Philadelphia, pp 2343\u20132396"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1128\/MCB.17.10.5771","volume":"17","author":"ES Knudsen","year":"1997","unstructured":"Knudsen ES, Wang JY (1997) Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 17:5771\u20135783","journal-title":"Mol Cell Biol"},{"key":"36_CR25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/modpathol.3800165","volume":"17","author":"T Kumada","year":"2004","unstructured":"Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5\u00a0years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141\u20131149","journal-title":"Mod Pathol"},{"key":"36_CR26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685\u2013688","journal-title":"Nature"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J Levitskaya","year":"1997","unstructured":"Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94:12616\u201312621","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2004.01.045","volume":"315","author":"XP Li","year":"2004","unstructured":"Li XP, Li G, Peng Y, Kung HF, Lin MC (2004) Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 315:212\u2013218","journal-title":"Biochem Biophys Res Commun"},{"key":"36_CR29","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/JVI.73.5.4385-4392.1999","volume":"73","author":"V Marechal","year":"1999","unstructured":"Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC (1999) Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73:4385\u20134392","journal-title":"J Virol"},{"key":"36_CR30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/309374a0","volume":"309","author":"MB Mathews","year":"1984","unstructured":"Mathews MB, Bernstein RM, Franza BR Jr, Garrels JI (1984) Identity of the proliferating cell nuclear antigen and cyclin. Nature 309:374\u2013376","journal-title":"Nature"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.onc.1201183","volume":"15","author":"E Mattia","year":"1997","unstructured":"Mattia E, Chichiarelli S, Hickish T, Gaeta A, Mancini C, Cunningham D, van Renswoude J (1997) Inhibition of in vitro proliferation of Epstein-Barr virus infected B cells by an antisense oligodeoxynucleotide targeted against EBV latent membrane protein LMP1. Oncogene 15:489\u2013493","journal-title":"Oncogene"},{"key":"36_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(02)00078-1","volume":"45","author":"JM Middeldorp","year":"2003","unstructured":"Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ (2003) Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45:1\u201336","journal-title":"Crit Rev Oncol Hematol"},{"key":"36_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0042-6822(84)90433-1","volume":"133","author":"A Polack","year":"1984","unstructured":"Polack A, Delius H, Zimber U, Bornkamm GW (1984) Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology 133:146\u2013157","journal-title":"Virology"},{"key":"36_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1073\/pnas.0235524100","volume":"100","author":"G Randall","year":"2003","unstructured":"Randall G, Grakoui A, Rice CM (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA 100:235\u2013240","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR35","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1128\/MCB.5.8.1822","volume":"5","author":"D Reisman","year":"1985","unstructured":"Reisman D, Yates J, Sugden B (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 5:1822\u20131832","journal-title":"Mol Cell Biol"},{"key":"36_CR36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.V84.2.582.582","volume":"84","author":"G Roth","year":"1994","unstructured":"Roth G, Curiel T, Lacy J (1994) Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 84:582\u2013587","journal-title":"Blood"},{"key":"36_CR37","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1073\/pnas.83.14.5096","volume":"83","author":"J Sample","year":"1986","unstructured":"Sample J, Hummel M, Braun D, Birkenbach M, Kieff E (1986) Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci USA 83:5096\u20135100","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR38","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1073\/pnas.88.14.6343","volume":"88","author":"J Sample","year":"1991","unstructured":"Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E (1991) Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 88:6343\u20136347","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR39","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1093\/emboj\/20.16.4588","volume":"20","author":"A Schepers","year":"2001","unstructured":"Schepers A, Ritzi M, Bousset K, Kremmer E, Yates JL, Harwood J, Diffley JF, Hammerschmidt W (2001) Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J 20:4588\u20134602","journal-title":"EMBO J"},{"key":"36_CR40","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1128\/JVI.63.6.2644-2649.1989","volume":"63","author":"B Sugden","year":"1989","unstructured":"Sugden B, Warren N (1989) A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63:2644\u20132649","journal-title":"J Virol"},{"key":"36_CR41","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-04-0079","volume":"64","author":"M Sugimoto","year":"2004","unstructured":"Sugimoto M, Tahara H, Ide T, Furuichi Y (2004) Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64:3361\u20133364","journal-title":"Cancer Res"},{"key":"36_CR42","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1128\/MCB.14.11.7144","volume":"14","author":"NS Sung","year":"1994","unstructured":"Sung NS, Wilson J, Davenport M, Sista ND, Pagano JS (1994) Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol Cell Biol 14:7144\u20137152","journal-title":"Mol Cell Biol"},{"key":"36_CR43","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/sj.onc.1206733","volume":"22","author":"RS Tomar","year":"2003","unstructured":"Tomar RS, Matta H, Chaudhary PM (2003) Use of adeno-associated viral vectors for delivery of small interfering RNA. Oncogene 22:5712\u20135715","journal-title":"Oncogene"},{"key":"36_CR44","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"JB Wilson","year":"1996","unstructured":"Wilson JB, Bell JL, Levine AJ (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15:3117\u20133126","journal-title":"EMBO J"},{"key":"36_CR45","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.81.12.3806","volume":"81","author":"J Yates","year":"1984","unstructured":"Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806\u20133810","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JVI.65.1.483-488.1991","volume":"65","author":"JL Yates","year":"1991","unstructured":"Yates JL, Guan N (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 65:483\u2013488","journal-title":"J Virol"},{"key":"36_CR47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","volume":"313","author":"JL Yates","year":"1985","unstructured":"Yates JL, Warren N, Sugden B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812\u2013815","journal-title":"Nature"},{"key":"36_CR48","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young LS, Murray PG (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108\u20135121","journal-title":"Oncogene"},{"key":"36_CR49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/nar\/26.2.631","volume":"26","author":"D Zhang","year":"1998","unstructured":"Zhang D, Frappier L, Gibbs E, Hurwitz J, O\u2019Donnell M (1998) Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res 26:631\u2013637","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-005-0036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-005-0036-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-005-0036-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T18:54:06Z","timestamp":1683226446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-005-0036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,23]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s00432-005-0036-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,23]]}}}